RecruitingNot ApplicableNCT05571514

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis: Multicentre, Double-blind Randomized Versus Positive Comparator Study


Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Enrollment

200 participants

Start Date

May 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity and mortality. Given potential side effects, hormone replacement therapy is no longer recommended for menopausal women with risk of becoming osteoporotic. The very significant decrease in the use of these treatments is suspected of contributing to a resurgence in the incidence of osteoporotic fractures, particularly in women before the age of 70. There is a need for prevention of osteoporosis.


Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 65 Years

Inclusion Criteria3

  • Post-menopausal women (50-65y) with risk of becoming osteoporotic
  • T-score between -1 and -3
  • Absence of fragility fractures history

Exclusion Criteria5

  • absence of parathyroid glands (phospho-calcic regulation)
  • presence of kidney stones
  • patients who follow a treatment that could interfere with bone metabolism (corticotherapy, menopausal hormonal therapy, anti-oestrogen treatment, non-controlled hyperthyroiditis, hyper- and hypothyroiditis)
  • bone diseases (Paget'disease, osteomalacia)
  • chronic alcoholism

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMother-of-pearl

The mother-of-pearl, derived from the inner shell of marine molluscs, is composed of calcium carbonate and organic compounds, some of which peptides are active on the bone. The mineralization inducing activity of the molecules extracted from the mother-of-pearl has been shown in vitro. Mother-of-pearl extract also contains molecules that inhibit the resorption activity of osteoclasts. Mother-of-pearl compounds can thus slow bone remodelling as showed in an ovariectomy-induced osteoporosis model in rat, where mother-of-pearl supplementation showed a better effect on limitation of bone loss than calcium carbonate supplementation.

DIETARY_SUPPLEMENTCalcium Carbonate

Calcium carbonate is a source of calcium.


Locations(7)

Hôpital Gabriel Montpied

Clermont-Ferrand, France

Clinique Universitaire de Rhumatologie

Grenoble, France

CH Emile Roux

Le Puy-en-Velay, France

Hôpital Edouard Herriot

Lyon, France

APHP - Hôpital Cochin

Paris, France

CH Roanne

Roanne, France

CHU Saint-Etienne

Saint-Etienne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05571514


Related Trials